Ventyx Biosciences, Inc.
Total raised
$192 M
3 rounds on record
Latest round
$27 M
Sep 2024
First round on record
Feb 2021
Today
Private
No later event on record
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Ventyx Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2024).
SEC Form D · Sep 2024
The industry group it chose in its notices: Other.
SEC Form D · Sep 2024
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
10 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Cormorant Global Healthcare Master Fund, LP | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Cormorant Private Healthcare Fund III LP | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| NSV Investments I, L.P. | Fund or asset manager | not stated | not stated | Held Series A and A-1 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| NSV Partners III GP LLC | Fund or asset manager | not stated | not stated | Held Series A and A-1 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| NSV Partners III LP | Fund or asset manager | not stated | not stated | Held Series A and A-1 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Sheila Gujrathi | Person | not stated | not stated | Held Series A preferred stock, director (Form 3, 2021) | SEC Form 3 |
| venBio Global Strategic Fund III, L.P. | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Venbio Global Strategic GP III, L.P. | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Venbio Global Strategic GP III, LTD | Company | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| John Nuss | Executive officer | Sep 2024 |
| Mark S. Forman | Executive officer | Sep 2024 |
| Matthew Moore | Executive officer | Sep 2024 |
| Raju Mohan | Executive officer | Sep 2024 |
| Christopher W. Krueger | Executive officer | Sep 2021 |
| Martin W. Auster | Executive officer | Sep 2021 |
| Raju W. Mohan | Executive officer | Sep 2021 |
| Allison S. Hulme | Director | Sep 2024 |
| Onaiza S. Cadoret-Manier | Director | Sep 2024 |
| Raju Mohan | Director | Sep 2024 |
| Sheila S. Gujrathi | Director | Sep 2024 |
| Somasundaram Subramaniam | Director | Sep 2024 |
| William S. White | Director | Sep 2024 |
| Aaron W. Royston | Director | Sep 2021 |
| Jigar W. Choksey | Director | Sep 2021 |
| Raju W. Mohan | Director | Sep 2021 |
| Richard W. Gaster | Director | Sep 2021 |
| Sheila W. Gujrathi | Director | Sep 2021 |
| Somasundaram W. Subramaniam | Director | Sep 2021 |
| William W. White | Director | Sep 2021 |